Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Timothy Sauber

Orthopaedic Surgery Pittsburgh, PA Medical Doctor

NPI 1003085671 CMS profile 226625

1307 Federal St Ste 2, Pittsburgh, PA 15212

Open in the dashboard

General payments

$373,389

419 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Timothy Sauber of Pittsburgh, PA is reported in the CMS Open Payments database as having received $373,389 across 419 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,624 21
2024 General $40,122 58
2023 General $34,272 40
2022 General $73,731 76
2021 General $51,496 62
2020 General $56,898 40
2019 General $109,247 122

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Timothy Sauber
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Timothy Sauber were reported at $7,624. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Timothy Sauber Orthopaedic Surgery median Middle half National median
2019 $109,247 $644 $140–$2,844 $163
2020 $56,898 $312 $75–$1,860 $114
2021 $51,496 $520 $117–$2,495 $132
2022 $73,731 $598 $128–$2,731 $149
2023 $34,272 $461 $128–$2,264 $160
2024 $40,122 $497 $134–$2,475 $164
2025 $7,624 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $356,262 348 payments
  2. Smith+Nephew, Inc. $8,944 20 payments
  3. Medical Device Business Services, Inc. $2,632 8 payments
  4. DePuy Synthes Sales Inc. $1,635 24 payments
  5. STERIS Instrument Management Services, Inc. $1,602 3 payments
  6. DePuy Synthes Products, Inc. $900 1 payment
  7. Innovation Technologies Inc $673 5 payments
  8. Zimmer Biomet Holdings, Inc. $424 5 payments
  9. Next Science LLC $115 1 payment
  10. Medtronic USA, Inc. $114 1 payment
  11. Other $87 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $314,341 100 payments
  2. Travel and Lodging $44,009 121 payments
  3. Food and Beverage $13,839 196 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,125 1 payment
  5. Education $75 1 payment
Products named General payments · program years 2019–2025
  1. MAKO Knees, Hips $128,351 162 payments
  2. MAKO Knees, Hips $114,789 97 payments
  3. ACCOLADE $33,139 14 payments
  4. TRITANIUM Hips $23,938 6 payments
  5. TRIATHLON $22,762 14 payments
  6. RESTORATION $21,900 8 payments
  7. TRIDENT Hips $20,914 8 payments
  8. UNIVERSAL NEURO 2 $10,050 2 payments
  9. TRITANIUM Hips $9,975 6 payments
  10. TRIDENT Hips $9,525 4 payments
  11. Other $88,987 131 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

425

Median for Orthopedic Surgery: 203

Drug cost

$5,577

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 91 $4,144
Doxycycline Hyclate Generic 16 $404
Naproxen Generic 17 $315
Amoxicillin Generic 193 $279
Ibuprofen Generic 37 $208
Meloxicam Generic 34 $98
Mupirocin Generic 12 $85
Clindamycin Hcl Generic 25 $44

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$103,573

Of which drugs: $460

Medicare patients

290

Average age 72

Services billed

2,719

180 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 24%
Ischemic heart disease 22%
Depression 18%
Osteoporosis 17%
Cancer 15%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 21 1,920 $190

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

419 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record